| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | FX3YKK43YM |
| Parent Compound: | PACTIMIBE |
| InChI Key | MKJQESRCXYYHFR-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C50H82N4O10S |
| Molecular Weight | 931.29 |
| AlogP | 5.64 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 10.0 |
| Polar Surface Area | 69.64 |
| Molecular species | ACID |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 30.0 |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Atherosclerosis; Hypercholesterolemia; Hyperlipoproteinemia Type II | Phase 2/Phase 3 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL447977 |
| EPA CompTox | DTXSID20209694 |
| FDA SRS | FX3YKK43YM |
| PubChem | 11953348 |